Alzheimer's Drug Discovery Foundation
Research-Services
Website
Company Tagline
Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer's
Industry Category
Business Keywords
Company Description
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to accelerating the discovery and development of drugs to prevent and treat Alzheimer's disease and related dementias. Founded in 1998, the Alzheimer's Drug Discovery Foundation operates with a venture philanthropy model, focusing solely on supporting innovative research initiatives aimed at combating this devastating condition. The Alzheimer's Drug Discovery Foundation's commitment has positioned it as a key player in the fight against Alzheimer's, funding numerous drug discovery programs and clinical trials worldwide. The ADDF is located at 57 West 57th Street, Suite 904, New York, NY 10019, US.
The Alzheimer's Drug Discovery Foundation employs a team of expert neuroscientists who identify and fund the most promising research projects globally. This hands-on approach ensures that a diverse and robust pipeline of potential treatments is constantly being explored. By focusing on cognitive aging, drug discovery, neuroscience, and biomarker development, the Alzheimer's Drug Discovery Foundation is making significant strides in understanding and treating Alzheimer's disease. The Alzheimer's Drug Discovery Foundation has awarded over $100 million to fund more than 550 Alzheimer’s drug discovery programs and clinical trials in 18 countries.
With a strong emphasis on innovation and collaboration, the Alzheimer's Drug Discovery Foundation is driving progress towards effective Alzheimer's treatments. The ADDF's strategic investments and expert oversight are helping to bring new therapies closer to reality, offering hope to millions affected by Alzheimer's. Alzheimer's Drug Discovery Foundation is a nonprofit organization. We invite the management team to create a customized and exclusive company showcase and product listing on our platform.
L'Alzheimer's Drug Discovery Foundation (ADDF) se consacre à l'accélération de la découverte et du développement de médicaments pour prévenir et traiter la maladie d'Alzheimer et les démences connexes. Fondée en 1998, l'Alzheimer's Drug Discovery Foundation fonctionne selon un modèle de philanthropie de risque, se concentrant uniquement sur le soutien aux initiatives de recherche innovantes visant à lutter contre cette maladie dévastatrice. L'engagement de l'Alzheimer's Drug Discovery Foundation l'a positionnée comme un acteur clé dans la lutte contre la maladie d'Alzheimer, finançant de nombreux programmes de découverte de médicaments et essais cliniques dans le monde entier. L'ADDF est située au 57 West 57th Street, Suite 904, New York, NY 10019, US.
L'Alzheimer's Drug Discovery Foundation emploie une équipe de neuroscientifiques experts qui identifient et financent les projets de recherche les plus prometteurs à l'échelle mondiale. Cette approche pratique garantit qu'un éventail diversifié et solide de traitements potentiels est constamment exploré. En se concentrant sur le vieillissement cognitif, la découverte de médicaments, les neurosciences et le développement de biomarqueurs, l'Alzheimer's Drug Discovery Foundation réalise des progrès significatifs dans la compréhension et le traitement de la maladie d'Alzheimer. L'Alzheimer's Drug Discovery Foundation a accordé plus de 100 millions de dollars pour financer plus de 550 programmes de découverte de médicaments contre la maladie d'Alzheimer et essais cliniques dans 18 pays.
En mettant fortement l'accent sur l'innovation et la collaboration, l'Alzheimer's Drug Discovery Foundation fait progresser la recherche de traitements efficaces contre la maladie d'Alzheimer. Les investissements stratégiques et la supervision experte de l'ADDF contribuent à rapprocher de nouvelles thérapies de la réalité, offrant ainsi de l'espoir à des millions de personnes touchées par la maladie d'Alzheimer. Alzheimer's Drug Discovery Foundation est une organisation à but non lucratif. Nous invitons l'équipe de direction à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Alzheimer's Drug Discovery Foundation with 3 companies in Research-Services
| Comparison Field |
Alzheimer's Drug Discover...Main Company |
BiognosysView Profile |
BioXcel Therapeutics...View Profile |
LipotypeView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2008 | 2017 | 2012 |
|
Company Size
|
— | 51-200 | 51-200 | 11-50 |
|
City
|
New York, NY | Schlieren, Zurich | New Haven, Connecticut | |
|
Country
|
United States | Switzerland | United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Alzheimer's research
Drug discovery
Neuroscience
Clinical trials
Biomarker development
Cognitive aging
Dementia treatment
Cognitive Aging
Drug Discovery
Biomarker Development
|
21 Total
21 Unique
Unique Skills:
Artificial Intelligence
Biomarker Discovery & Validation
Chronic Diseases
Clinical studies
Contract Research Services
Data Analytics
+15
|
10 Total
10 Unique
Unique Skills:
Artificial Intelligence
Big Data
Clinical Pharmacology
Clinical Research
Clinical Trials
Immuno-oncology
+4
|
18 Total
18 Unique
Unique Skills:
Artificial Intelligence
Biomarker Discovery & Validation
Cell Biology
Clinical Studies
Contract Research Services
Dermatology
+12
|
4
Total Companies2008
Oldest Founded2
Countries51
Unique SkillsSimilar Companies
Other organizations in the same industry
Alternative Company Names
This company is also known as